A 55-year-old man presented with a painless and slowly developing mass in the right superior lateral eyelid region. He had sustained periorbital blunt injury about 4 years previously. The mass was observed several months later in the persisting traumatic tumefaction region. Computed tomography showed a cystic soft-tissue mass with central low density and peripheral enhancement over the upper anterior quadrant of the right orbit. Lateral orbitotomy was performed to remove the lesion. Histopathologic examination showed proliferation of epithelial and myoepithelial cells arranged in ductules and nests in the myxoid stroma. Benign pleomorphic adenoma of the lacrimal gland associated with traumatic tumefaction, as demonstrated in our patient, may be rare.

Keywords:
Pleomorphic adenoma, Trauma
1.
Shields CL, Shields JA, Eagle RC, Rathmell JP: Clinicopathologic review of 142 cases of lacrimal gland lesions. Ophthalmology 1989;96:431–435.
2.
Rose GE, Wright JE: Pleomorphic adenoma of the lacrimal gland. Br J Ophthalmol 1992;76:395–400.
3.
Yamada T, Kato T, Hayasaka S, Hayasaka Y, Kadoi C: Benign pleomorphic adenoma arising from the palpebral lobe of the lacrimal gland associated with elevated intraocular pressure. Ophthalmologica 1999;213:269–272.
4.
Auran J, Jakobiec FA, Krebs W: Benign mixed tumor of the palpebral lobe of the lacrimal gland: Clinical diagnosis and appropriate surgical management. Ophthalmology 1988;95:90–99.
5.
Parks SL, Glover AT: Benign mixed tumors arising in the palpebral lobe of the lacrimal gland. Ophthalmology 1990;97:526–530.
6.
Abassi-Bakir D, Turki A, Laarif M, Gharbi-Jemni H, Khochtali H, Graies-Tlili K, Kraiem C, Bakir A: Post-traumatic adenoid cystic carcinoma of the lacrimal gland. Rev Stomatol Chir Maxillofac 1998;98:339–342.
7.
Wharton JA, O’Donnell BA: Unusual presentations of pleomorphic adenoma and adenoid cystic carcinoma of the lacrimal gland. Aust NZ J Ophthalmol 1999;27:145–148.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.